Latest news and press releases about Creative Medical Technology Holdings, Inc. (CELZ): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology.
Price
| Price | $0.82 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.35 |
| EV / EBITDA | 0.96 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -86.70% |
| Return on Invested Capital | -71.90% |
| Return on Assets | -64.42% |
| Gross Margin | -1732.37% |
| Operating Margin | -208004.40% |
| Net Margin | -201355.37% |
Related companies: ACXP · ADIL · ADXN · ALZN · APRE · BCDA · CDIO
Explore sector: Healthcare · Biotechnology
More sections of CELZ: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks